The Engineering and Operations team at Xenios AG, a Fresenius Medical Care company, specializes in developing and optimizing ECMO treatments and technologies for patients with cardiac and pulmonary failure. This team collaborates to design, manage, and enhance processes and engineering projects, ensuring the seamless integration and functionality of cardiac and pulmonary support platforms. Their collective efforts focus on improving treatment efficacy and expanding the capabilities of extracorporeal multi-organ support systems.